2008 JASN IMPACT FACTOR 7.505	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text (Rapid PDF) All Versions of this Article: ASN.2005020144v1 16/12/3687    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meerwaldt, R. Articles by Smit, A. J. Search for Related Content PubMed PubMed Citation Articles by Meerwaldt, R. Articles by Smit, A. J.

Received February 5, 2005
Accepted on September 27, 2005

CLINICAL SCIENCE: Clinical Nephrology

Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Predicts Mortality in Hemodialysis Patients

Robbert Meerwaldt ^*1, Jasper W.L. Hartog ^*, Reindert Graaff , Roel J. Huisman , Thera P. Links ^*, Nynke C. den Hollander ^*, Susan R. Thorpe , John W. Baynes , Gerjan Navis ^*, Rijk O.B. Gans ^*, and Andries J. Smit ^*

Departments of *Medicine and Biomedical Engineering University Medical Center Groningen, University of Groningen, and Dialysis Center Groningen, Groningen, the Netherlands; and Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina

¹ To whom correspondence should be addressed. E-mail: r.meerwaldt{at}isala.nl.

	Abstract

Tissue advanced glycation end products (AGE) are a measure of cumulative metabolic stress and trigger cytokines driven inflammatory reactions. AGE are thought to contribute to the chronic complications of diabetes and ESRD. Tissue autofluorescence is related to the accumulation of AGE. Therefore, skin autofluorescence (AF) may provide prognostic information on mortality in hemodialysis (HD) patients. Skin AF was measured noninvasively with an AF reader at baseline in 109 HD patients. Overall and cardiovascular mortality was monitored prospectively during a period of 3 yr. The AF reader was validated against AGE contents in skin biopsies from 29 dialysis patients. Forty-two of the 109 (38.5%) HD patients died. Cox regression analysis showed that AF was an independent predictor of overall and cardiovascular mortality (for overall mortality odds ratio [OR] 3.9), as were pre-existing cardiovascular disease (CVD; OR 3.1), C-reactive protein (OR 1.1), and serum albumin (OR 0.3). Multivariate analysis revealed that 65% of the variance in AF could be attributed to the independent effects of age, dialysis and renal failure duration, presence of diabetes, triglycerides levels, and C-reactive protein. AF was also independently linked to the presence of CVD at baseline (OR 8.8; P < 0.001). AF correlated with collagen-linked fluorescence (r = 0.71, P < 0.001), pentosidine (r = 0.75, P < 0.001), and carboxy(m)ethyllysine (both r = 0.45, P < 0.01). Skin AF is a strong and independent predictor of mortality in ESRD. This supports a role for AGE as a contributor to mortality and CVD and warrants interventions specifically aimed at AGE accumulation.

This article has been cited by other articles:

				E. G. Gerrits, A. J. Smit, and H. J. G. Bilo AGEs, autofluorescence and renal function Nephrol. Dial. Transplant., March 1, 2009; 24(3): 710 - 713. [Full Text] [PDF]

				C. W. McIntyre, S. G. John, and H. J. Jefferies Advances in the cardiovascular assessment of patients with chronic kidney disease NDT Plus, December 1, 2008; 1(6): 383 - 391. [Abstract] [Full Text] [PDF]

				R. Meerwaldt, T. Links, C. Zeebregts, and A. Smit RE: "PLASMA FLUORESCENT OXIDATION PRODUCTS AS POTENTIAL MARKERS OF OXIDATIVE STRESS FOR EPIDEMIOLOGIC STUDIES" Am. J. Epidemiol., March 15, 2008; 167(6): 756 - 757. [Full Text] [PDF]

				E. G. Gerrits, H. L. Lutgers, N. Kleefstra, R. Graaff, K. H. Groenier, A. J. Smit, R. O. Gans, and H. J. Bilo Skin Autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications Diabetes Care, March 1, 2008; 31(3): 517 - 521. [Abstract] [Full Text] [PDF]

				J. W.L. Hartog, A. A. Voors, C. G. Schalkwijk, J. Scheijen, T. D.J. Smilde, K. Damman, S. J.L. Bakker, A. J. Smit, and D. J. van Veldhuisen Clinical and prognostic value of advanced glycation end-products in chronic heart failure Eur. Heart J., December 1, 2007; 28(23): 2879 - 2885. [Abstract] [Full Text] [PDF]

				J. W.L. Hartog, A. A. Voors, S. J.L. Bakker, A. J. Smit, and D. J. van Veldhuisen Advanced glycation end-products (AGEs) and heart failure: Pathophysiology and clinical implications Eur J Heart Fail, December 1, 2007; 9(12): 1146 - 1155. [Abstract] [Full Text] [PDF]

				J. V. Glenn, J. R. Beattie, L. Barrett, N. Frizzell, S. R. Thorpe, M. E Boulton, J. J. McGarvey, and A. W. Stitt Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging FASEB J, November 1, 2007; 21(13): 3542 - 3552. [Abstract] [Full Text] [PDF]

				K. de Leeuw, R. Graaff, R. de Vries, R. P. Dullaart, A. J. Smit, C. G. Kallenberg, and M. Bijl Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus Rheumatology, October 1, 2007; 46(10): 1551 - 1556. [Abstract] [Full Text] [PDF]

				S. Bengmark Advanced Glycation and Lipoxidation End Products-Amplifiers of Inflammation: The Role of Food JPEN J Parenter Enteral Nutr, September 1, 2007; 31(5): 430 - 440. [Abstract] [Full Text] [PDF]

				F. Galli Protein damage and inflammation in uraemia and dialysis patients Nephrol. Dial. Transplant., July 1, 2007; 22(suppl_5): v20 - v36. [Abstract] [Full Text] [PDF]

				R. Meerwaldt, H. L. Lutgers, T. P. Links, R. Graaff, J. W. Baynes, R. O.B. Gans, and A. J. Smit Skin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes Diabetes Care, January 1, 2007; 30(1): 107 - 112. [Abstract] [Full Text] [PDF]

				H. Koyama, T. Shoji, S. Fukumoto, K. Shinohara, T. Shoji, M. Emoto, K. Mori, H. Tahara, E. Ishimura, R. Kakiya, et al. Low Circulating Endogenous Secretory Receptor for AGEs Predicts Cardiovascular Mortality in Patients With End-Stage Renal Disease Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 147 - 153. [Abstract] [Full Text] [PDF]

				H. L. Lutgers, R. Graaff, T. P. Links, L. J. Ubink-Veltmaat, H. J. Bilo, R. O. Gans, and A. J. Smit Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes Diabetes Care, December 1, 2006; 29(12): 2654 - 2659. [Abstract] [Full Text] [PDF]

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673